Skip to content

Anti-endomysial antibody (serum/plasma) – Immunoassay

Published: August 9, 2026Updated: August 16, 2026

This test measures antibodies against endomysium, a protein found in the muscle fibers of the small intestine. It helps diagnose certain types of celiac disease.

Quick summary

["This test may be used to confirm suspected celiac disease."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
13092-2
Short code
Endomysium Ab Ser-aCnc
Synonyms
Endomysium Ab Ser-aCnc
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why is this test done?

Your doctor may order this test if you have symptoms like persistent diarrhea, abdominal pain, weight loss, or fatigue, and they suspect celiac disease. It can also be part of a routine screening for people with a family history of the condition or certain autoimmune diseases.

What does a positive result mean?

A positive result strongly suggests celiac disease, as these antibodies are specific to the tissue affected in this condition. However, a positive test alone doesn’t confirm the diagnosis—additional testing, like a biopsy of the small intestine, is usually needed.

What does a negative result mean?

A negative result means your body does not have detectable anti-endomysial antibodies. This could mean you don’t have celiac disease, but it’s not definitive. Other conditions or factors may also cause a negative result, so further evaluation may still be needed.

How is this test performed?

A blood sample is taken from a vein in your arm. The sample is sent to a lab where antibodies against endomysium are measured using an immunoassay method. This test is typically done on serum or plasma.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Anti-endomysial antibodies are highly specific markers for celiac disease. When present, they indicate damage to the small intestine’s lining, which occurs when gluten is consumed. Early detection through this test can help manage symptoms and prevent long-term complications like nutrient deficiencies or increased risk of other autoimmune diseases.

Short name

Anti-endomysial antibody (AEA)

Frequently asked questions

What are the common symptoms of celiac disease?
Common symptoms include chronic diarrhea, abdominal pain, bloating, weight loss, fatigue, anemia, or a failure to thrive in children. Some people may not have symptoms at all, especially in adults.
How is celiac disease diagnosed?
Diagnosis involves a combination of blood tests (like anti-endomysial antibodies), a gluten-free trial, and an intestinal biopsy. The biopsy confirms damage to the small intestine, which is the gold standard for diagnosis.
Can this test be done at home?
No, this test requires a blood sample collected by a healthcare professional. Some labs may offer at-home blood collection kits, but interpretation and follow-up care must still be done by a doctor.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy